首页> 美国卫生研究院文献>BMC Cardiovascular Disorders >Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial
【2h】

Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial

机译:(S)-氨氯地平与常规氨氯地平三联治疗高血压的腿部水肿:一项随机双盲对照临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundLeg edema is a common adverse effect of dihydropyridine Calcium Channel Blockers (CCB) that may need dose reduction or drug withdrawal, adversely affecting the antihypertensive efficacy. Leg edema is reported to occur less often with (S)-amlodipine compared to conventional racemic amlodipine. We aimed to find the incidence of leg edema as a primary outcome and antihypertensive efficacy with (S)-amlodipine compared to conventional amlodipine.
机译:背景腿水肿是二氢吡啶钙通道阻滞剂(CCB)的常见不良反应,可能需要降低剂量或停用药物,从而对降压功效产生不利影响。据报道,与常规消旋氨氯地平相比,(S)-氨氯地平下肢水肿的发生率更低。我们的目标是发现与传统的氨氯地平相比,(S)-氨氯地平的腿部水肿的发生是主要结局,并具有降压功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号